NEW YORK, May 14, 2024 /PRNewswire/ — Mason Capital Management LLC, a Delaware limited liability company (“Mason Capital”), announced today that it has commenced a tender offer (the “Tender Offer”) for any and all the outstanding ADSs and Ordinary Shares in Forward Pharma A/S (the “Company”) for a purchase price of $437.00 per ADS or […]
COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) Forward Pharma A/S (“Forward” or the “Company”) today announced that its Board of Directors has approved a termination of the Deposit Agreement, dated October 14, 2014, among Forward Pharma A/S (Forward Pharma), the Depositary Bank of New York Mellon, and Owners and Holders of ADRs. As a result, the existing ADR facility will be terminated effective at 5:00 PM (Eastern Time) on February 5, 2024. Kindly see additional information at the websi
Forward Pharma A/S Announces Termination of its American Depositary Receipts ("ADR") Facility streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia’s Board of Directors August 18, 2023
Dr. Daniel G. Billen appointed Chair of the Board of Directors
.
Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia’s Board of Directors August 18, 2023Dr. Daniel G. Billen appointed Chair of the Board of DirectorsEDMONTON, Alberta (BUSINESS WIRE) Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors has appointed.